T Scientific Co.,Ltd. (KOSDAQ:057680)
South Korea · Delayed Price · Currency is KRW 1,769.00
-8.00 (-0.45%)
At close: Sep 3, 2026
T Scientific Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 34,457 | 36,366 | 43,017 | 26,769 | 8,694 | 10,084 |
Other Revenue | -0 | - | - | - | - | - |
| 34,457 | 36,366 | 43,017 | 26,769 | 8,694 | 10,084 | |
Revenue Growth | -13.73% | -15.46% | 60.70% | 207.89% | -13.78% | -66.14% |
Cost of Revenue | 24,396 | 25,366 | 33,116 | 18,685 | 4,510 | 5,833 |
Gross Profit | 10,060 | 11,000 | 9,901 | 8,084 | 4,184 | 4,250 |
Selling, General & Admin | 7,482 | 7,534 | 8,361 | 11,235 | 5,517 | 2,538 |
Research & Development | 2,074 | 2,050 | 1,265 | 902.9 | 273.43 | 296.59 |
Amortization of Goodwill & Intangibles | 51.55 | 64.27 | 150.66 | 170 | 124.78 | 92.93 |
Other Operating Expenses | 148.46 | 184.19 | 406.9 | 438.4 | 360.24 | 135.47 |
Operating Expenses | 10,533 | 10,736 | 20,533 | 13,700 | 6,676 | 3,247 |
Operating Income | -472.21 | 264.33 | -10,632 | -5,616 | -2,492 | 1,004 |
Interest Expense | -920.24 | -786.3 | -866.07 | -2,711 | -2,938 | -1,285 |
Interest & Investment Income | 171.26 | 184.27 | 342.04 | 488.13 | 555.77 | 136.53 |
Currency Exchange Gain (Loss) | 3.58 | 2.55 | -5.02 | -0 | 0.04 | - |
Other Non Operating Income (Expenses) | -3,169 | -1,029 | 8,371 | -5,678 | -2,380 | -1,405 |
EBT Excluding Unusual Items | -4,387 | -1,365 | -2,790 | -13,516 | -7,254 | -1,550 |
Gain (Loss) on Sale of Investments | 1,033 | -812.86 | 3,466 | -14,018 | -8,590 | -1,417 |
Gain (Loss) on Sale of Assets | -15.13 | -1,414 | -203.75 | 16.6 | -46.48 | 7.95 |
Asset Writedown | -1,257 | -1,257 | -115.73 | -26,707 | - | - |
Other Unusual Items | - | - | 951.9 | -37.64 | - | - |
Pretax Income | -4,626 | -4,849 | 1,308 | -54,262 | -15,890 | -2,959 |
Income Tax Expense | -3,250 | -3,250 | -981.28 | -5,525 | -4,082 | 202.86 |
Earnings From Continuing Operations | -1,376 | -1,599 | 2,289 | -48,737 | -11,808 | -3,162 |
Minority Interest in Earnings | 293.66 | 318.58 | -65.9 | 3,323 | 698 | - |
Net Income | -1,083 | -1,281 | 2,223 | -45,414 | -11,110 | -3,162 |
Net Income to Common | -1,083 | -1,281 | 2,223 | -45,414 | -11,110 | -3,162 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 14 | 14 | 14 | 12 | 11 | 9 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 12 | 11 | 9 |
Shares Change | 0.38% | 1.13% | 14.29% | 16.46% | 12.96% | 183.72% |
EPS (Basic) | -75.61 | -89.87 | 157.79 | -3683.54 | -1049.53 | -337.39 |
EPS (Diluted) | -75.74 | -90.00 | 157.79 | -3685.00 | -1050.00 | -337.39 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1,280 | 638.15 | -13,259 | -11,388 | -2,667 | -123.56 |
Free Cash Flow Per Share | -89.37 | 44.78 | -940.95 | -923.71 | -251.97 | -13.19 |
Gross Margin | 29.20% | 30.25% | 23.02% | 30.20% | 48.13% | 42.15% |
Operating Margin | -1.37% | 0.73% | -24.71% | -20.98% | -28.66% | 9.96% |
Profit Margin | -3.14% | -3.52% | 5.17% | -169.65% | -127.79% | -31.36% |
Free Cash Flow Margin | -3.71% | 1.75% | -30.82% | -42.54% | -30.68% | -1.23% |
EBITDA | 381.84 | 1,275 | -9,282 | -4,279 | -2,067 | 1,269 |
EBITDA Margin | 1.11% | 3.51% | -21.58% | -15.99% | -23.77% | 12.59% |
D&A For EBITDA | 854.05 | 1,011 | 1,349 | 1,337 | 425.18 | 265.68 |
EBIT | -472.21 | 264.33 | -10,632 | -5,616 | -2,492 | 1,004 |
EBIT Margin | -1.37% | 0.73% | -24.71% | -20.98% | -28.66% | 9.96% |
Advertising Expenses | - | 79.83 | 64.18 | 25.32 | 35.82 | 25.77 |